Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 316
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 188
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 160
Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
Arshpreet Kaur, Jeremy Baldwin, Deshkanwar Brar, et al.
Current Opinion in Chemical Biology (2022) Vol. 70, pp. 102172-102172
Open Access | Times Cited: 102
A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion
Seung Mo Jin, Yeon Jeong Yoo, Hong Sik Shin, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 4, pp. 390-402
Open Access | Times Cited: 70
Materials engineering strategies for cancer vaccine adjuvant development
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 55
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 21
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 20
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Alessandra Cesano, Ryan C. Augustin, Luigi Barrea, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e008876-e008876
Open Access | Times Cited: 2
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 61
Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 50
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 5184-5232
Open Access | Times Cited: 45
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Lilit Grigoryan, Audrey Lee, Alexandra C. Walls, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 42
Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy
Lijia Luo, Xiang Wang, Yu‐Pei Liao, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 13168-13182
Open Access | Times Cited: 41
Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination
Jianqin Wan, Lulu Ren, Xiaoyan Li, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 39
Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation
Sachin Bhagchandani, Farrukh Vohidov, Lauren E. Milling, et al.
Science Advances (2023) Vol. 9, Iss. 16
Open Access | Times Cited: 31
Supramolecular Biomaterials for Cancer Immunotherapy
Huan Liang, Qingqing Lu, Jie Yang, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 27
Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations
Sivakumar S. Moni, Siddig İbrahim Abdelwahab, Aamena Jabeen, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 25
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 23
A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors
Bihan Wu, Juan Liang, Xuejiao Yang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8585-8597
Closed Access | Times Cited: 15
Polarization of macrophages to an anti-cancer phenotype through in situ uncaging of a TLR 7/8 agonist using bioorthogonal nanozymes
Xianzhi Zhang, Yuanchang Liu, Mingdi Jiang, et al.
Chemical Science (2024) Vol. 15, Iss. 7, pp. 2486-2494
Open Access | Times Cited: 13
Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer
Shahad K. Alsaiari, Seba Nadeef, John L. Daristotle, et al.
Science Advances (2024) Vol. 10, Iss. 10
Open Access | Times Cited: 10
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 10
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top